Paul Ngheim

发表

Pilot trial of intratumoral (IT) G100, a toll-like receptor-4 (TLR4) agonist, in patients (pts) with Merkel cell carcinoma (MCC): Final clinical results and immunologic effects on the tumor microenvironment (TME).

D. Byrd, Hailing Lu, U. Parvathaneni, 2016 .